As severe underweight and cardiovascular anomalies are important clinical features of the peripheral thyrotoxicosis of MCT8 deficiency and underlie substantial morbidity and mortality, amelioration of these thyrotoxic features likely benefits patients with MCT8 deficiency at all ages. Here, SLC16A2 is linked to thyrotoxicosis.